Osteoporosis 2001
DOI: 10.1016/b978-012470862-4/50070-2
|View full text |Cite
|
Sign up to set email alerts
|

Estrogens and Osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 199 publications
0
1
0
Order By: Relevance
“…In conditions of estrogen deficiency, there is increased production of inflammatory cytokines, as interleukines: IL-1, IL-6, IL-11 and tumour necrosis factors (TNF), these factors stimulate osteoclasts formation. Estrogen has antiresorptive effect as it promotes bone formation by regulating osteoblast proliferation, differentiation and activity and it stimulates the production of antiosteoclastogenic factors including Interleukin-1 receptor antagonist(43). Also Estrogen deficiency increases the stromal production of receptors activator of NFKB ligand (RANKL) and macrophage colony stimulating factor (M-CSF)(44).…”
mentioning
confidence: 99%
“…In conditions of estrogen deficiency, there is increased production of inflammatory cytokines, as interleukines: IL-1, IL-6, IL-11 and tumour necrosis factors (TNF), these factors stimulate osteoclasts formation. Estrogen has antiresorptive effect as it promotes bone formation by regulating osteoblast proliferation, differentiation and activity and it stimulates the production of antiosteoclastogenic factors including Interleukin-1 receptor antagonist(43). Also Estrogen deficiency increases the stromal production of receptors activator of NFKB ligand (RANKL) and macrophage colony stimulating factor (M-CSF)(44).…”
mentioning
confidence: 99%